TNF-α is another mast cell mediator that has long been implicated in the pathogenesis of inflammatory bowel diseases such as ulcerative colitis and Crohn’s disease where TNF-α inhibitors such as infliximab have been mainstays of therapy. This evidence concerns the gene TNF and ulcerative colitis.